From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

Featured Article

HIV/AIDS Clinical Care Supporting Image

ANTIRETROVIRAL ROUNDS

Is She or Isn't She?Free

An HIV-infected pregnant woman says she's taking her antiretrovirals — but the blood test results say otherwise. How would you manage?

Special Notice

Meeting Update Icon

News from the 2009 San Antonio Breast Cancer Symposium

The Editor-in-Chief of Journal Watch Oncology and Hematology discusses key findings presented at the 2009 San Antonio Breast Cancer Symposium.

Recent Articles

CLINICAL PRACTICE GUIDELINE WATCH

Recommended Adult Immunization Schedule for 2010

Few changes this year

SUMMARY AND COMMENT

Risk Index Is Adequate for Predicting Perioperative Cardiac Complications

But the RCRI is not so predictive for death or for complications of vascular surgery.

SUMMARY AND COMMENT

Cultural Competence Training Isn't Associated with Better Diabetes Outcomes

Awareness of racial disparities didn't translate into better glucose, lipid, or blood pressure control.

SUMMARY AND COMMENT

Pregnancy and Childbirth in Women with MSFree

  • Neurology

Two studies add important information about the mutual influences of pregnancy and MS.

SUMMARY AND COMMENT

Delayed Cerebral Thrombosis After Pneumococcal Meningitis

  • Neurology

A case-series analysis suggests that delayed stroke after initial good recovery may be an immune-mediated phenomenon in patients treated with adjunctive dexamethasone therapy.

SUMMARY AND COMMENT

Diffusion-Weighted Imaging in Normal-Pressure Hydrocephalus

  • Neurology

Can DWI differentiate reversible changes caused by NPH from irreversible microangiopathic changes within periventricular white matter?

SUMMARY AND COMMENT

High-Flow Oxygen for Cluster Headache

  • Neurology

A randomized crossover trial finds this treatment effective.

SUMMARY AND COMMENT

Imatinib Dosing for Patients with Chronic-Phase CML

Higher dosing was associated with more early-onset responses than standard dosing, but response rates at each dose were similar after 1 year of therapy.

SUMMARY AND COMMENT

Nilotinib as Initial Therapy for Patients with CML

In two studies, treatment with nilotinib resulted in rapid induction and high rates of remission in patients with chronic-phase CML.

SUMMARY AND COMMENT

Initial Antiretroviral Therapy — Switching Still Common

In an observational cohort study, treatment changes within the first year of therapy were common but did not reduce rates of virologic suppression.

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Copyright © 2010. Massachusetts Medical Society. All rights reserved.